Evommune, Inc. Common Stock (EVMN)

Other Income/Expenses (Net)

$2.65M

Quarterly · Period ending: · USD

EVMN logo

EVMN Other Income/Expenses (Net)

Latest reported$2.65M
EVMN Quarterly Other Income/Expenses (Net) ($970.00K → $2.65M)
High-resolution chart · PNG

EVMN other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
2,649,000
2,280,000
1,443,000
853,000
9,429,000
475,000
664,000
601,000
907,000
970,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.